Macrolides, lincosamides and streptogramins systemic use: consumption in Europe 2022
This statistic displays the hospital consumption of macrolides, lincosamides and streptogramins (J01F) for systemic use in Europe in 2022, by country. The defined daily dose (DDD) of macrolides, lincosamides, and streptogramins per 1,000 inhabitants per day in the hospital sector in Italy amounted to 0.16 in that year.